AS-202

N/A

Report date: 2024/11/06 16:37:58
NME

Base Information

Drug NameAS-202
Drug Alias NameAS202AS-202AS2AS-2TAK-212
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of Action1-phosphatidylinositol 3-phosphate 5-kinase inhibitors
Targets1-phosphatidylinositol 3-phosphate 5-kinase
Therapy Area/IndicationsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcurastem Inc
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdAcurastem Inc
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A